Spyre Therapeutics, Inc. (SYRE) rose 11.31% to $21.06, up $2.14, following the announcement of a $275 million public offering of common stock at $18.50 per share.
The stock opened at $19.15, hit a high of $21.41 and a low of $18.30, versus a previous close of $18.92. It trades on the NASDAQ, with a volume of 2.87 million shares, sharply above its average.
The 52-week range is $12.10 to $21.41.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.